Immuron Limited (IMRN) Financials

IMRN Assets vs Liabilities
DateAssetsLiabilities
Dec. 31, 2023 13.5 million 1.6 million
June 30, 2023 14.6 million 1.6 million
March 31, 2023 14.8 million 1.6 million
Dec. 31, 2022 15.7 million 1.3 million

IMRN Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Dec. 31, 2023 ? ?
June 30, 2023 -1.0 million 75284
March 31, 2023 -538190 76157
Dec. 31, 2022 -646787 ?

IMRN Net Income

No data available :(

IMRN Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Dec. 31, 2023 11.2 million - -
June 30, 2023 12.6 million - 125449
March 31, 2023 11.5 million - -
Dec. 31, 2022 13.0 million - 131326

IMRN Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Dec. 31, 2023 155.2 million
June 30, 2023 151.1 million
March 31, 2023 152.9 million
Dec. 31, 2022 155.2 million

IMRN Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Dec. 31, 2023 - 1.8 million - -
June 30, 2023 445 710207 783186 154788
March 31, 2023 225 359221 792268 156583
Dec. 31, 2022 4813 1.0 million 633455 156940

IMRN Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Dec. 31, 2023 1.6 million 528165
June 30, 2023 810086 225454
March 31, 2023 409740 30569
Dec. 31, 2022 397566 106077

IMRN

Price: $1.16

52 week price:
0.68
2.39

Earnings Per Share: -0.64 USD

P/E Ratio: -1.18

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: Australia

Volume: 1327

Ebitda: -6.8 million

Market Capitalization: 8.1 million

Links: